Anxiolytic effect of methylene blue microinjected into the dorsal periaqueductal gray matter.
The dorsal periaqueductal gray (DPAG) has been implicated in the behavioral and autonomic expression of defensive reactions. Several results suggest that, along with GABA, glutamate and serotonin, nitric oxide (NO) may play a role in defense reactions mediated by this region. To further investigate this possibility we microinjected methylene blue (MB; 10, 30 or 100 nmol/0.5 microl) into the DPAG of rats submitted to the elevated plus-maze test, an animal model of anxiety. MB has been used as an inhibitor of soluble guanylate cyclase (sGC) to demonstrate cGMP-mediated processes, and there is evidence that NO may exert its biological effects by binding to the heme part of guanylate cyclase, causing an increase in cGMP levels. The results showed that MB (30 nmol) significantly increased the percent of time spent in the open arms (saline = 11.57 +/- 1.54, MB = 18.5 +/- 2.45, P<0.05) and tended to do the same with the percentage of open arm entries (saline = 25.8 +/- 1.97, MB = 33. 77 +/- 3.07, P<0.10), but did not change the number of enclosed arm entries. The dose-response curve, however, had an inverted U shape. These results indicate that MB, within a limited dose range, has anxiolytic properties when microinjected into the DPAG.
de-Oliveira
R W
RW
Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil.
Guimarães
F S
FS
D000818:Animals; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D008297:Male; D018782:Maze Learning; D008751:Methylene Blue / Q000627:therapeutic use*; D008845:Microinjections; D009569:Nitric Oxide / Q000037:antagonists & inhibitors* / Q000502:physiology; D010487:Periaqueductal Gray; D051381:Rats; D017208:Rats, Wistar
D014151:Anti-Anxiety Agents; D004791:Enzyme Inhibitors; D009569:Nitric Oxide; D008751:Methylene Blue